The dysfunctional autonomic function and “dysfunctional” fatigue in drug naïve Parkinson’s disease
Objective: In the present study, the relationship between fatigue and autonomic dysfunction in drug-naïve PD patients was investigated. Background: Fatigue is a common and disabling…Clinical characteristics of pain in Parkinson’s disease dementia
Objective: The aim of this study was the assess the prevalence of pain in Parkinson’s disease dementia, its clinical characteristics, and correlations with motor part…Long-term quality of life after subthalamic deep brain stimulation depends on non-motor symptoms in Parkinson’s disease
Objective: To predict 36-month follow-up quality of life (QoL) outcome after bilateral subthalamic nucleus deep brain stimulation (STN-DBS) in Parkinson’s disease (PD). Background: STN-DBS improves…Depression in Parkinson’s Disease: perspectives from an Australian cohort
Objective: This study aimed to identify clinical predictors and management implications for depression in an Australian cohort of Parkinson’s disease (PD) patients. Background: Depression is…Pain Syndromes in Parkinsonism Depending on the Form Disease
Objective: To study of pain syndromes in various forms of Parkinsonism. Background: Pain can occur in the premotor stage of Parkinson's disease, motor signs are…Prevalence of non-motor symptoms in Parkinson’s disease using the Movement Disorder Society-Non-Motor Rating Scale (MDS-NMS) and comparable scales
Objective: To analyze the frequency and differences in distribution by sex and disease severity of non-motor symptoms (NMS) in patients with Parkinson’s disease (PD) using…Sexual dysfunction precedes the classical motor symptoms of Parkinson’s disease?
Objective: To investigate whether sexual dysfunction precedes the classical motor symptoms of Parkinson’s disease. Background: There is growing evidence that some symptoms can precede the…A Parkinson’s disease (PD) case with underlying cerebral small vessel disease (CSVD)
Objective: Emphasis of CSVD in PD through clinical-pathological correlation study. Background: PD affects 1.7%, while CSVD affects about 45% [1], of the population aged over…Parkinson’s disease and osteocalcin pilot study: Is there a protective role of bone in neurodegeneration?
Objective: To characterize the relationship between the bone-derived hormone osteocalcin (OCN) and Parkinson’s disease (PD) in humans, and explore sex and treatment differences. Background: The…Neuroimaging of anxiety in Parkinson’s disease: a systematic review
Objective: The aim of this systematic review was 1) to identify the brain regions involved in anxiety in Parkinson's disease (PD) based on neuroimaging studies,…
- « Previous Page
- 1
- …
- 34
- 35
- 36
- 37
- 38
- …
- 149
- Next Page »